Published in Endocrinol Metab Clin North Am on September 28, 2011
The influence of sporadic anovulation on hormone levels in ovulatory cycles. Hum Reprod (2013) 1.57
The Arcuate Estrogen-Regulated Transcriptome: Estrogen Response Element-Dependent and -Independent Signaling of ERα in Female Mice. Endocrinology (2017) 0.75
AURORA: bariatric surgery registration in women of reproductive age - a multicenter prospective cohort study. BMC Pregnancy Childbirth (2016) 0.75
The interaction of fasting, caloric restriction, and diet-induced obesity with 17β-estradiol on the expression of KNDy neuropeptides and their receptors in the female mouse. Mol Cell Endocrinol (2016) 0.75
The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril (2008) 5.31
Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. J Clin Endocrinol Metab (2006) 4.56
The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum Reprod (2009) 3.74
Safety and efficacy of a testosterone metered-dose transdermal spray for treating decreased sexual satisfaction in premenopausal women: a randomized trial. Ann Intern Med (2008) 3.25
Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Fertil Steril (2011) 2.80
Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society. J Clin Endocrinol Metab (2010) 2.48
Metformin in polycystic ovary syndrome: systematic review and meta-analysis. BMJ (2003) 2.40
Glucose tolerance abnormalities in Australian women with polycystic ovary syndrome. Med J Aust (2007) 2.03
Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update (2010) 1.86
Differences in recognition of the 1st WHO international reference reagents for hCG-related isoforms by diagnostic immunoassays for human chorionic gonadotropin. Clin Chem (2009) 1.82
Definition and significance of polycystic ovarian morphology: a task force report from the Androgen Excess and Polycystic Ovary Syndrome Society. Hum Reprod Update (2013) 1.81
Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. Cochrane Database Syst Rev (2012) 1.76
Lifestyle changes in women with polycystic ovary syndrome. Cochrane Database Syst Rev (2011) 1.47
Treatment of obesity in polycystic ovary syndrome: a position statement of the Androgen Excess and Polycystic Ovary Syndrome Society. Fertil Steril (2008) 1.44
Power Doppler assessment of follicle vascularity at the time of oocyte retrieval in in vitro fertilization cycles. Fertil Steril (2008) 1.44
Obesity increases the risk of spontaneous abortion during infertility treatment. Obes Res (2002) 1.42
Peroxisome proliferator-activated receptor-gamma agonist rosiglitazone reverses the adverse effects of diet-induced obesity on oocyte quality. Endocrinology (2008) 1.41
Obese women exhibit differences in ovarian metabolites, hormones, and gene expression compared with moderate-weight women. J Clin Endocrinol Metab (2009) 1.40
Macrophage contributions to ovarian function. Hum Reprod Update (2004) 1.35
Beta-oxidation is essential for mouse oocyte developmental competence and early embryo development. Biol Reprod (2010) 1.34
Comparison of clomiphene citrate, metformin, or the combination of both for first-line ovulation induction, achievement of pregnancy, and live birth in Asian women with polycystic ovary syndrome: a randomized controlled trial. Fertil Steril (2008) 1.30
Influence of acupuncture stimulation on pregnancy rates for women undergoing embryo transfer. Fertil Steril (2006) 1.30
High-fat diet causes lipotoxicity responses in cumulus-oocyte complexes and decreased fertilization rates. Endocrinology (2010) 1.29
The effect of a hypocaloric diet with and without exercise training on body composition, cardiometabolic risk profile, and reproductive function in overweight and obese women with polycystic ovary syndrome. J Clin Endocrinol Metab (2008) 1.29
Assessment and management of polycystic ovary syndrome: summary of an evidence-based guideline. Med J Aust (2011) 1.23
Obesity and menstrual irregularity: associations with SHBG, testosterone, and insulin. Obesity (Silver Spring) (2009) 1.22
Lifestyle changes in women with polycystic ovary syndrome. Cochrane Database Syst Rev (2011) 1.22
Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. Cochrane Database Syst Rev (2010) 1.21
Preconception lifestyle advice for people with subfertility. Cochrane Database Syst Rev (2010) 1.16
Programming and reproductive functioning. Trends Endocrinol Metab (2002) 1.14
Surgically obtained sperm, and risk of gestational hypertension and pre-eclampsia. Lancet (2002) 1.11
Insulin resistance increases the risk of spontaneous abortion after assisted reproduction technology treatment. J Clin Endocrinol Metab (2007) 1.10
Lifestyle management improves quality of life and depression in overweight and obese women with polycystic ovary syndrome. Fertil Steril (2009) 1.08
Impact of obesity on female fertility and fertility treatment. Womens Health (Lond Engl) (2008) 1.07
Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. Cochrane Database Syst Rev (2009) 1.06
Knowledge about factors that influence fertility among Australians of reproductive age: a population-based survey. Fertil Steril (2012) 1.05
Aromatase inhibitors for PCOS: a systematic review and meta-analysis. Hum Reprod Update (2012) 1.04
Incidence of spontaneous abortion among pregnancies produced by assisted reproductive technology. Hum Reprod (2004) 1.02
Short-term meal replacements followed by dietary macronutrient restriction enhance weight loss in polycystic ovary syndrome. Am J Clin Nutr (2006) 1.02
Single embryo transfer reduces the risk of perinatal mortality, a population study. Hum Reprod (2012) 1.01
Androgens and polycystic ovary syndrome. Curr Opin Endocrinol Diabetes Obes (2009) 0.99
Increased beta-oxidation and improved oocyte developmental competence in response to l-carnitine during ovarian in vitro follicle development in mice. Biol Reprod (2011) 0.98
Polycystic ovary syndrome is associated with severe platelet and endothelial dysfunction in both obese and lean subjects. Atherosclerosis (2008) 0.98
Serum antimullerian hormone (AMH) levels are elevated in adolescent girls with polycystic ovaries and the polycystic ovarian syndrome (PCOS). Fertil Steril (2010) 0.98
C-reactive protein before and after weight loss in overweight women with and without polycystic ovary syndrome. J Clin Endocrinol Metab (2007) 0.98
The longer-term health outcomes for children born as a result of IVF treatment. Part II--Mental health and development outcomes. Hum Reprod Update (2013) 0.97
Genetic and gene expression analyses of the polycystic ovary syndrome candidate gene fibrillin-3 and other fibrillin family members in human ovaries. Mol Hum Reprod (2009) 0.96
The longer-term health outcomes for children born as a result of IVF treatment: Part I--General health outcomes. Hum Reprod Update (2013) 0.95
Multifetal pregnancy reduction of triplet and higher-order multiple pregnancies to twins. Fertil Steril (2004) 0.94
Exposure to lipid-rich follicular fluid is associated with endoplasmic reticulum stress and impaired oocyte maturation in cumulus-oocyte complexes. Fertil Steril (2012) 0.94
Determinants of adverse perinatal outcome in high-risk women with abnormal uterine artery Doppler images. Am J Obstet Gynecol (2008) 0.93
Ehlers-Danlos syndrome: insights on obstetric aspects. Obstet Gynecol Surv (2007) 0.92
Infertility caused by HCG autoantibody. J Clin Endocrinol Metab (2002) 0.92
Effects of lifestyle modification in polycystic ovarian syndrome. Reprod Biomed Online (2006) 0.92
Expression of leptin and its receptor in the murine ovary: possible role in the regulation of oocyte maturation. Biol Reprod (2002) 0.92
Polycystic ovarian syndrome: marked differences between endocrinologists and gynaecologists in diagnosis and management. Clin Endocrinol (Oxf) (2005) 0.91
Endoplasmic reticulum (ER) stress in cumulus-oocyte complexes impairs pentraxin-3 secretion, mitochondrial membrane potential (DeltaPsi m), and embryo development. Mol Endocrinol (2012) 0.90
Prevalence of polycystic ovary syndrome in a sample of Indigenous women in Darwin, Australia. Med J Aust (2012) 0.90
Postprandial ghrelin, cholecystokinin, peptide YY, and appetite before and after weight loss in overweight women with and without polycystic ovary syndrome. Am J Clin Nutr (2007) 0.89
Tissue and circulating microRNA influence reproductive function in endometrial disease. Reprod Biomed Online (2013) 0.88
Single or multiple embryo transfer following in vitro fertilisation for improved neonatal outcome: a systematic review of the literature. Aust N Z J Obstet Gynaecol (2004) 0.88
Soluble adhesion molecules in serum throughout the menstrual cycle. Hum Reprod (2002) 0.87
Extent of metabolic risk in adolescent girls with features of polycystic ovary syndrome. Fertil Steril (2011) 0.87
PPAR Gamma: Coordinating Metabolic and Immune Contributions to Female Fertility. PPAR Res (2008) 0.86
The use of anti-mullerian hormone in predicting menstrual response after weight loss in overweight women with polycystic ovary syndrome. J Clin Endocrinol Metab (2007) 0.86
Genome instability is increased in lymphocytes of women with polycystic ovary syndrome and is correlated with insulin resistance. Mutat Res (2007) 0.86
The impact of obesity on oocytes: evidence for lipotoxicity mechanisms. Reprod Fertil Dev (2011) 0.86
Leptin and leptin receptor expression in the rat ovary. Endocrinology (2003) 0.85
Psychological effects of prescriptive vs general lifestyle advice for weight loss in young women. J Am Diet Assoc (2009) 0.85
The treatment of infertility in polycystic ovary syndrome: a brief update. Aust N Z J Obstet Gynaecol (2012) 0.84
Dietary therapy in polycystic ovary syndrome. Semin Reprod Med (2008) 0.84
Towards less confusing terminology in reproductive medicine: clarifying medical ambiguities to the benefit of all. Hum Reprod (2005) 0.84
Polycystic ovary syndrome: perceptions and attitudes of women and primary health care physicians on features of PCOS and renaming the syndrome. J Clin Endocrinol Metab (2013) 0.84
Diagnosis of adolescent polycystic ovary syndrome. Steroids (2013) 0.84
Troglitazone regulates peroxisome proliferator-activated receptors and inducible nitric oxide synthase in murine ovarian macrophages. Biol Reprod (2005) 0.84
Acupuncture to improve live birth rates for women undergoing in vitro fertilization: a protocol for a randomized controlled trial. Trials (2012) 0.84
Dietary effects on fertility treatment and pregnancy outcomes. Curr Opin Endocrinol Diabetes Obes (2007) 0.84
Identification of perilipin-2 as a lipid droplet protein regulated in oocytes during maturation. Reprod Fertil Dev (2010) 0.84
Effect of a synthetic progestin on the exercise status of sedentary young women. J Clin Endocrinol Metab (2005) 0.84
Effect of a very-low-calorie diet on in vitro fertilization outcomes. Fertil Steril (2006) 0.83
Clinical update: obstetric anaesthesia. Lancet (2007) 0.83
Assessment of androgen concentration in women: liquid chromatography-tandem mass spectrometry and extraction RIA show comparable results. Eur J Endocrinol (2011) 0.83
Status of clomiphene citrate and metformin for infertility in PCOS. Trends Endocrinol Metab (2012) 0.83
Periovulatory expression of intercellular adhesion molecule-1 in the rat ovary. Biol Reprod (2004) 0.83
Metformin versus clomiphene citrate for infertility in non-obese women with polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update (2012) 0.82
Emerging concepts about prenatal genesis, aberrant metabolism and treatment paradigms in polycystic ovary syndrome. Endocrine (2012) 0.82
Overweight infertile patients have a higher fecundity than normal-weight women undergoing controlled ovarian hyperstimulation with intrauterine insemination. Fertil Steril (2004) 0.82
Impact of menstrual cycle phase on the exercise status of young, sedentary women. Eur J Appl Physiol (2003) 0.82
The prevention and treatment of intrauterine growth restriction. Best Pract Res Clin Obstet Gynaecol (2009) 0.82
Tibolone and transdermal E2/NETA for the treatment of female sexual dysfunction in naturally menopausal women: results of a randomized active-controlled trial. J Sex Med (2008) 0.82
Heart rate recovery improves after weight loss in overweight and obese women with polycystic ovary syndrome. Fertil Steril (2009) 0.81
Prenatal determinants of uterine volume and ovarian reserve in adolescence. J Clin Endocrinol Metab (2009) 0.81
Does in vitro fertilisation increase type 2 diabetes and cardiovascular risk? Curr Diabetes Rev (2011) 0.80
Circulating maternal testosterone concentrations at 18 weeks of gestation predict circulating levels of antimüllerian hormone in adolescence: a prospective cohort study. Fertil Steril (2010) 0.80
Hyperandrogenemia, psychological distress, and food cravings in young women. Physiol Behav (2009) 0.79
Preimplantation genetic diagnosis for beta-thalassaemia using sequencing of single cell PCR products to detect mutations and polymorphic loci. Mol Hum Reprod (2002) 0.79
Reducing multiple pregnancy from assisted reproduction treatment: educating patients and medical staff. Med J Aust (2006) 0.78
Weight loss and vascular inflammatory markers in overweight women with and without polycystic ovary syndrome. Reprod Biomed Online (2012) 0.77
WITHDRAWN: Insulin-sensitising drugs for polycystic ovary syndrome. Cochrane Database Syst Rev (2009) 0.77